Ongoing Care and Optimization Regular follow-up visits allow us to monitor your progress, adjust dosing, manage any side effects, and retest labs as needed
Patients should seek prompt medical guidance for severe or persistent vomiting, signs of dehydration, severe abdominal pain, fainting, symptoms of low blood sugar, inability to keep fluids down, worsening constipation with pain or bloating, or any symptom that feels unsafe
All these findings potentiate the assumption that GLP-1RAs use is associated with hepato-biliary-pancreatic biochemical changes (Table 2)
This article is written for a US audience
Real providers
Results Study population characteristics A total of 417,322 patients with AKI who required dialysis were discharged from the hospital